Pharmaceutical Market Europe • September 2022 • 16
MAXINE SMITH
Maxine Smith
The language we use at work has changed dramatically over the last couple of years. Terms such as ‘sprint’, ‘waterfall’ and ‘scrum’ have filtered through from the tech industry and it is rare to go a week without the mention of ‘Agile’.
The ‘Agile’ methodology is very powerful when used in the right way. Many teams are making huge strides by accessing the benefits working collaboratively using Agile for the delivery of digital solutions.
But can Agile be a strategy development tool in pharma? Can it help with planning or launch or the introduction of new capabilities? Through our work with clients, we have increasingly seen that by taking a very practical, accessible approach to Agile, it can catapult teams forward in their productivity, cross-functional teamwork and innovative thinking.
The magic ingredients to make ‘Agile’ work for pharma
The language we use at work has changed dramatically over the last couple of years. Terms such as ‘sprint’, ‘waterfall’ and ‘scrum’ have filtered through from the tech industry and it is rare to go a week without the mention of ‘Agile’.
The ‘Agile’ methodology is very powerful when used in the right way. Many teams are making huge strides by accessing the benefits working collaboratively using Agile for the delivery of digital solutions.
But can Agile be a strategy development tool in pharma?
Can it help with planning or launch or the introduction of new capabilities? Through our work with clients, we have increasingly seen that by taking a very practical, accessible approach to Agile, it can catapult teams forward in their productivity, cross-functional teamwork and innovative thinking.
So, what seems to be the magic ingredients of success?
The first magic ingredient is to ensure that it is applied to the right problem.
Agile works when it is applied to a specific question or challenge when the answer is not clear, or where different approaches have failed in the past, eg large cross-functional team projects. It doesn’t work well when the teams know the answer they seek and they want to ‘bring people on the journey’ or gain specific input. So, we don’t believe Agile works well to complete brand plan templates but looking at how brand planning can be more customer-centric is a great challenge to be tackled in this way. Equally, it can be applied successfully where the subject matter expertise is important, when sharing experience is critical and where it is complex to access appropriate solutions, eg how to maximise artificial intelligence in rare diseases.
Secondly, you need leadership buy-in. A leader that is bought into the concept of Agile provides space for the team to work, empowers the team to make decisions and doesn’t let perfection be the enemy of productivity, which is vital.
Finally, you need to get the team right. The SLAM (self-organising, lean, autonomous and multidisciplinary) team must have no more than six people to be productive and to move forward at speed. The product owner needs to champion the needs to the user and ensure that they are front and centre in the development of the solution. Finally, the team needs to be facilitated by an expert scrum master.
We have acted in the scrum master role for over 200 pharma clients and have found that having an external scrum master who has deep subject matter expertise, who can also bring other elements such as design thinking or behavioural economics, enables teams to rapidly move forward as they know what to listen for and really connect Agile to the core of the challenge that drives a different output.
So, what are the benefits, I hear you ask?
Uptake has found by taking this practical approach to Agile, it can help teams to:
Maxine Smith is Director and Alexandra Fulford is Senior Consultant, both at Uptake Strategies